Bright Minds Biosciences Inc (DRUG)

Currency in CAD
44.69
0.00(0.00%)
Delayed Data·

DRUG Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Buy

Summary:Strong Buy

Moving Averages:BuyBuy: (9)Sell: (3)
Technical Indicators:Strong BuyBuy: (11)Sell: (0)

Technical Indicators

Summary: Strong BuyBuy: 11Neutral: 0Sell: 0
Aug 7, 2025 13:35 GMT
Name
Value
Action
RSI(14)58.293Buy
STOCH(9,6)76.648Buy
STOCHRSI(14)69.187Buy
MACD(12,26)1.62Buy
ADX(14)31.275Buy
Williams %R-31.588Buy
CCI(14)70.6311Buy
ATR(14)2.3207High Volatility
Highs/Lows(14)4.0464Buy
Ultimate Oscillator63.282Buy
ROC21.243Buy
Bull/Bear Power(13)4.782Buy

Moving Averages

Summary: BuyBuy: 9Sell: 3
Aug 7, 2025 13:35 GMT
Name
Simple
Exponential
MA5
46.67
Sell
44.84
Sell
MA10
42.25
Buy
43.16
Buy
MA20
39.06
Buy
41.27
Buy
MA50
41.00
Buy
41.96
Buy
MA100
46.08
Sell
42.71
Buy
MA200
42.64
Buy
39.04
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic45.2145.3745.6845.8446.1546.3146.62
Fibonacci45.3745.5545.6645.8446.0246.1346.31
Camarilla45.8745.9145.9645.8446.0446.0946.13
Woodie's45.2945.4145.7645.8846.2346.3546.7
DeMark's--45.7745.8846.24--

FAQ

From a Technical Analysis Perspective, Is Bright Minds Biosciences a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Do the Moving Averages for DRUG Currently Stand?

The moving averages for Bright Minds Biosciences show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 9 Buy signals and 3 Sell signals.

What Is the Current Status of the Technical Indicators for Bright Minds Biosciences?

The technical indicators for Bright Minds Biosciences are in a Strong Buy position based on daily analysis, with 11 signals on buy indicators and 0 sell signals.

What Is DRUG's 14-Day RSI?

The current Relative Strength Index (RSI) of DRUG over the 14-day period is 58.293, which suggests that the stock is a Buy.

What Is DRUG's MACD?

DRUG's MACD is 1.620, which suggests that the stock is a Buy.

What Is DRUG's 5-Day Moving Average?

DRUG's 5-day moving average is 46.67, suggesting that the stock is a Sell.

What Is DRUG's 50-Day Moving Average?

DRUG's 50-day moving average is 41.00, suggesting that the stock is a Buy.

What Is DRUG's 200-Day Moving Average?

DRUG's 200-day moving average is 42.64, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for DRUG?

The Fibonacci pivot point performance value for DRUG is 45.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.